MedPath

Assessment of anxiolytic activity of Mundi (Sphaeranthus indicus Linn) in patients of Generalized Anxiety Disorder.

Phase 3
Conditions
Health Condition 1: F411- Generalized anxiety disorder
Registration Number
CTRI/2024/03/064361
Lead Sponsor
ALL INDIA INSTITUTE OF AYURVEDA, NEW DELHI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

A.Patients fulfilling the criteria of Generalized Anxiety Disorder as per DSM V guidelines.

B.Hamilton anxiety score more than 17.

C.Age 20 to 40 years, irrespective to gender, caste, socio-economic status etc.

Exclusion Criteria

1.Patient suffering from any psychiatric disorder other than GAD.

2.Patient suffering from any major systemic disease requiring significant care.

3.Patient with serious suicidal & Homicidal risk, substance, or alcohol dependence.

4.Pregnant women and lactating mothers.

5.Patient not willing to participate in study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HARS LESS THAN 17Timepoint: HARS LESS THAN 17
Secondary Outcome Measures
NameTimeMethod
IMPROVEMENT IN GAD 7 SCALETimepoint: AFTER 2 MONTHS
© Copyright 2025. All Rights Reserved by MedPath